US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 27, 2021 (5 years ago)

Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32

Recalling firm
Glenmark Pharmaceuticals Inc., USA
NDC code
68462-317-32
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0820-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fulvestrant recalls

See all